Get the Stockscreener App
3.62
3.43%
0.12
Pre-market:
3.61
-0.01
-0.28%
Ardelyx Inc stock is traded at $3.62, with a volume of 3.98M.
It is up +3.43% in the last 24 hours and down -6.94% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$3.50
Open:
$3.54
24h Volume:
3.98M
Relative Volume:
0.94
Market Cap:
$934.64M
Revenue:
$427.68M
Net Income/Loss:
$-58.06M
P/E Ratio:
-15.20
EPS:
-0.2382
Net Cash Flow:
$-37.50M
1W Performance:
+6.47%
1M Performance:
-6.94%
6M Performance:
-31.83%
1Y Performance:
-41.80%
1-Day Range:
$3.47
$3.63
1-Week Range:
$3.33
$3.63
52-Week Range:
$3.33
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
3.62 | 924.31M | 427.68M | -58.06M | -37.50M | -0.2382 |
VRTX
Vertex Pharmaceuticals Inc
|
514.99 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.90 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
182.56 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
963.79 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
368.08 | 39.20B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Sep-03-25 | Resumed | Raymond James | Strong Buy |
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
ARDX Edges Up After Hours On IBSRELA Momentum And Profitability ‘Right Around The Corner’ - Stocktwits
Ardelyx (ARDX) Could Be 72% Undervalued Following Its September Investor Conference Run - simplywall.st
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug - Stocktwits
Ardelyx at cantor global healthcare conference: growth meets payer pressure - investing.com
ARDX: Profitability targeted by 2027 as IBSRELA and XPHOZAH drive growth amid payer and market shifts - TradingView
Ardelyx at cantor global healthcare conference: growth meets payer pressure By Investing.com - Investing.com UK
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%? - Stocktwits
Ardelyx Inc (ARDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ardelyx (ARDX) Has Investors Looking Closer, But What Is Driving The Attention? - simplywall.st
Ardelyx CHRO James Brady sells $58,378 in stock By Investing.com - Investing.com Nigeria
Ardelyx CHRO James Brady sells $58,378 in stock - Investing.com
Ardelyx to Participate in Upcoming Investor Conferences - Yahoo Finance
Have Insiders Sold Ardelyx Shares Recently? - simplywall.st
Ardelyx chief patient officer sells $41,419 in stock By Investing.com - Investing.com Australia
Ardelyx chief patient officer sells $41,419 in stock - Investing.com India
Ardelyx CCO Eric Foster sells $33,022 in stock By Investing.com - Investing.com Canada
Ardelyx CCO Eric Foster sells $33,022 in stock - Investing.com India
Ardelyx CBO Mike Kelliher sells $29,921 in shares By Investing.com - Investing.com Canada
Ardelyx CEO Michael Raab sells $225,914 in ARDX stock By Investing.com - Investing.com Canada
Ardelyx chief technical officer John Bishop sells $76,173 in stock By Investing.com - Investing.com Canada
Ardelyx chief human resources officer sells $58,378 in stock By Investing.com - Investing.com Nigeria
Ardelyx chief technical officer John Bishop sells $76,173 in stock - Investing.com India
Ardelyx SVP Joseph Reilly sells $15,358 of company stock By Investing.com - Investing.com Nigeria
Ardelyx SVP Joseph Reilly sells $15,358 of company stock - Investing.com India
Ardelux CFO Susan Hohenleitner sells $6,009 in shares - investing.com
Ardelyx (ARDX) Cuts Guidance On Payer Hurdles As Fair Value Debate Heats Up - Yahoo Finance
Ardelyx (NASDAQ: ARDX) holder plans tax sale of vesting shares - Stock Titan
Ardelyx (NASDAQ: ARDX) exec plans 10,500-share RSU tax sale - Stock Titan
Ardelyx (NASDAQ: ARDX) insider plans $179K stock sale - Stock Titan
Ardelyx (NASDAQ: ARDX) plans RSU tax-cover sale of 10,500 shares - Stock Titan
Ardelyx (ARDX) exec to sell $18.9K in shares for RSU taxes - Stock Titan
Ardelyx (NASDAQ: ARDX) shareholder John Bishop plans 25,500-share sale - Stock Titan
Ardelyx (NASDAQ: ARDX) officer plans stock sales and tax-cover trades - Stock Titan
Ardelyx (ARDX) officer to sell 11,900 shares for RSU taxes - Stock Titan
334,115 Shares in Ardelyx, Inc. $ARDX Acquired by Clay Northam Wealth Management LLC - MarketBeat
Ardelyx (ARDX) Securities Investigation NoticeLevi & Korsinsky - Morningstar
Ardelyx (NASDAQ:ARDX) Sets New 52-Week LowHere's Why - MarketBeat
Ardelyx (ARDX) Earnings Update: EPS Falls Short of Its Estimate under the Current Snapshot; Investor Response: Shares Fall 2.61% at the CloseRevenue Inflection Point - vinanet.vn
Ardelyx (ARDX) Following Strong Results And Guidance Still Looks Undervalued - simplywall.st
ARDX Reiterates by Wedbush -- Price Target Maintained at $9.00 - GuruFocus
Exploring 3 High Growth Tech Stocks In The US Market - Sahm
Ardelyx Chief Commercial Officer Announces Upcoming Resignation - The Globe and Mail
Ardelyx (ARDX) Q2 2026 Earnings Call Transcript - AOL.com
Ardelyx, Inc. (ARDX) Latest Stock News & Headlines - Yahoo Finance
Wedbush Reiterates Outperform Rating for Ardelyx (NASDAQ:ARDX) - MarketBeat
Ardelyx Leads The Charge With These 3 Compelling Penny Stocks - Sahm
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Ardelyx Inc Stock (ARDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Reilly Joseph James | See Remarks |
Aug 21 '26 |
Sale |
3.86 |
3,982 |
15,358 |
145,854 |
| Bishop John E | See Remarks |
Aug 21 '26 |
Sale |
3.86 |
19,750 |
76,174 |
317,095 |
| Brady James Parker | Chief Human Resources Officer |
Aug 21 '26 |
Sale |
3.86 |
15,136 |
58,378 |
245,930 |
| Foster Eric Duane | Chief Commercial Officer |
Aug 21 '26 |
Sale |
3.86 |
8,562 |
33,023 |
409,410 |
| Kelliher Mike | Chief Business Officer |
Aug 21 '26 |
Sale |
3.86 |
7,758 |
29,922 |
349,660 |
| Williams Laura A | Chief Patient Officer |
Aug 21 '26 |
Sale |
3.86 |
10,739 |
41,419 |
367,456 |
| RAAB MICHAEL | President & CEO |
Aug 21 '26 |
Sale |
3.86 |
58,574 |
225,914 |
1,619,792 |
0.14%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):